Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ab147c8f58a6f84c229509b95eefea7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259045c6eba6e2c5d338b84e0a88b571 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
filingDate |
2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f74db12ff2feef75a8228688f37e72f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_293d3517bd1ec4746c21ead412fc1829 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db143ee3259bb5c3fce1cfe8e6d35cb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6de05ded770c4a47c744b41749b5e73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f71a1f0d1df21ee52c8647ed93ebec4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04afb31841a1a3aa8e85fae3a4f87480 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdc1a99ea81de5110de0391a4128fa2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_194eb8a079aae99c11f817f045b56ee7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853e20abeb3c19e41aa9c50f3c8c105a |
publicationDate |
2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20050046301-A |
titleOfInvention |
Composition comprising phellinus gilvus mycelium extract for immunologically active enhancement |
abstract |
The present invention relates to a composition for enhancing immune activity containing Felinus vaginal mycelium extract.n n n Felinus vaginal mycelium extract of the present invention is active in macrophages in vivo, and specifically increases the splenic immune cells and B cell activity among spleen immune cells, thereby preventing immune-related diseases such as cancer. And pharmaceuticals and health foods useful for treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009072687-A1 |
priorityDate |
2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |